Amauri Chaves Filho

Amauri Chaves Filho

Auto-generated profile, based on publicly available information

Amauri Chaves Filho

Santa Casa de Misericórdia Vitória, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Coluna/Columna
Verified
Journal Article
Open access
AFAmauri Chaves Filho
Amauri Chaves Filho
JQJeinnifer Zanardo Quaggiotto
Jeinnifer Zanardo Quaggiotto
IZIgor de Barcellos Zanon
Igor de Barcellos Zanon
JJJosé Lucas Batista Júnior
José Lucas Batista Júnior
ICIgor Machado Cardoso
Igor Machado Cardoso
CJCharbel Jacob Júnior
Charbel Jacob Júnior
Objective: To compare quality of life in patients with longer fusions with that of those who have short fusions 2 years of after surgery. Methods: This is a retrospective comparative cohort study (Level of Evidence III) involving patients with adolescent idiopathic scoliosis who underwent posterior spinal fusion with pedicle screws with a 2-year follow-up. The primary outcome was quality of life assessed using the SRS-30 questionnaire. Participants were divided according to Lenke and stratified into those with major (Lenke 3 and Lenke 6) and minor (Lenke 1 and Lenke 5) fusions. Results: Forty-one patients, 34 of whom were women, were evaluated: Lenke 1 (17 patients), Lenke 3 (15 patients), Lenke 5 (3 patients), and Lenke 6 (6 patients). The mean age was 13.8 years, the mean preoperative and postoperative Cobb angles were 56.48 degrees and 10.49 degrees, respectively, and the mean surgical Cobb reduction was 45.54 degrees. All patients in the sample showed an overall improvement in quality of life after surgery (p0.05). Although pain was improved in the overall sample, this was not the case for the group with structured double curves and longer fusions (p = 0.03). Conclusion: There was no difference in quality of life between patients with long and short fusions with a 2-year follow-up. Level of Evidence III; Retrospective cohort.